Findings show that vaginal estrogen therapy does not increase endometrial cancer recurrence risk in survivors, indicating safety.
Endometrial cancer survivors with short-term exposure to vaginal ET did not have an elevated risk of endometrial cancer recurrence compared with those without vaginal ET.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: